
    
      50 infants and toddlers will be enrolled in this study to yield 40 completed subjects, 30
      babies in the active treatment group and 10 babies in the positive control group.

      Infants and toddlers aged 6 to 47 months inclusive will receive either a prescription or
      non-marketed investigational product for the treatment of eczema. Caregivers will be asked to
      stop use of prescription eczema treatments one week before the start of the study and during
      the study. Caregivers will apply study product to babies as indicated for 14 days to affected
      areas.

      Subject caregivers will record treatment use in a daily diary and complete questionnaires. A
      dermatologist will examine and score the babies eczema and symptoms. Skin moisture levels
      will also be tested.
    
  